Validation of an ICD-9-Based Algorithm to Identify Stillbirth Episodes from Medicaid Claims Data.


Journal

Drug safety
ISSN: 1179-1942
Titre abrégé: Drug Saf
Pays: New Zealand
ID NLM: 9002928

Informations de publication

Date de publication:
05 2023
Historique:
accepted: 01 03 2023
medline: 8 5 2023
pubmed: 13 4 2023
entrez: 12 4 2023
Statut: ppublish

Résumé

In administrative data, accurate timing of exposure relative to gestation is critical for determining the effect of potential teratogen exposure on pregnancy outcomes. To develop an algorithm for identifying stillbirth episodes in the ICD-9-CM era using national Medicaid claims data (1999-2014). Unique stillbirth episodes were identified from clusters of medical claims using a hierarchy that identified the encounter with the highest potential of including the actual stillbirth delivery and that delineated subsequent pregnancy episodes. Each episode was validated using clinical detail on retrieved medical records as the gold standard. Among 220 retrieved records, 197 were usable for validation of 1417 stillbirth episodes identified by the algorithm. The positive predictive value (PPV) was 64.0% (57.3-70.7%) overall, 80.4% (73.8-87.1%) for inpatient episodes, 28.2% (14.1-42.3%) for outpatient-only episodes, and 20.0% (2.5-37.5%) for outpatient episodes with overlapping hospitalizations. The absolute difference between the dates of the algorithm-specified stillbirth delivery and the medical record-based event was 4.2 ± 24.3 days overall, 1.7 ± 7.7 days for inpatient episodes, 14.3 ± 51.4 days for outpatient-only episodes, and 1.0 ± 2.0 days for outpatient episodes that overlapped with a hospitalization. Excluding all outpatient episodes, as well as pregnancies involving multiple births, the PPV increased to 82.7% (76.8-89.8%). Our algorithm to identify stillbirths from administrative claims data had a moderately high PPV. Positive predictive value was substantially increased by restricting the setting to inpatient episodes and using only input diagnostic codes for singleton stillbirths.

Identifiants

pubmed: 37043168
doi: 10.1007/s40264-023-01287-3
pii: 10.1007/s40264-023-01287-3
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

457-465

Informations de copyright

© 2023. The Author(s), under exclusive licence to Springer Nature Switzerland AG.

Références

Hornbrook MC, Hurtado AV, Johnson RE. Health care episodes: definition, measurement and use. Med Care Rev. 1985;42(2):163–218.
doi: 10.1177/107755878504200202 pubmed: 10274864
Zhu Y, Hampp C, Wang X, Albogami Y, Wei YJ, Brumback BA, et al. Validation of algorithms to estimate gestational age at birth in the Medicaid Analytic eXtract-Quantifying the misclassification of maternal drug exposure during pregnancy. Pharmacoepidemiol Drug Saf. 2020;29(11):1414–22.
doi: 10.1002/pds.5126 pubmed: 32909348
Margulis AV, Setoguchi S, Mittleman MA, Glynn RJ, Dormuth CR, Hernández-Díaz S. Algorithms to estimate the beginning of pregnancy in administrative databases. Pharmacoepidemiol Drug Saf. 2013;22(1):16–24.
doi: 10.1002/pds.3284 pubmed: 22550030
Li Q, Andrade SE, Cooper WO, Davis RL, Dublin S, Hammad TA, et al. Validation of an algorithm to estimate gestational age in electronic health plan databases. Pharmacoepidemiol Drug Saf. 2013;22(5):524–32.
doi: 10.1002/pds.3407 pubmed: 23335117 pmcid: 3644383
Eworuke E, Hampp C, Saidi A, Winterstein AG. An algorithm to identify preterm infants in administrative claims data. Pharmacoepidemiol Drug Saf. 2012;21(6):640–50.
doi: 10.1002/pds.3264 pubmed: 22504840
Fitzpatrick T, Wilton AS, Guttmann A. Development and validation of a simple algorithm to estimate common gestational age categories using standard administrative birth record data in Ontario, Canada. J Obstet Gynaecol. 2021;41(2):207–11.
doi: 10.1080/01443615.2020.1726304 pubmed: 32590915
Hornbrook MC, Whitlock EP, Berg CJ, Callaghan WM, Bachman DJ, Gold R, et al. Development of an algorithm to identify pregnancy episodes in an integrated health care delivery system. Health Serv Res. 2007;42(2):908–27.
doi: 10.1111/j.1475-6773.2006.00635.x pubmed: 17362224 pmcid: 1955367
Manson JM, McFarland B, Weiss S. Use of an automated database to evaluate markers for early detection of pregnancy. Am J Epidemiol. 2001;154(2):180–7.
doi: 10.1093/aje/154.2.180 pubmed: 11447053
Matcho A, Ryan P, Fife D, Gifkins D, Knoll C, Friedman A. Inferring pregnancy episodes and outcomes within a network of observational databases. PLoS ONE. 2018;13(2): e0192033.
doi: 10.1371/journal.pone.0192033 pubmed: 29389968 pmcid: 5794136
Bertoia ML, Phiri K, Clifford CR, Doherty M, Zhou L, Wang LT, et al. Identification of pregnancies and infants within a US commercial healthcare administrative claims database. Pharmacoepidemiol Drug Saf. 2022;31(8):863–74.
doi: 10.1002/pds.5483 pubmed: 35622900 pmcid: 9546262
Moll K, Wong HL, Fingar K, Hobbi S, Sheng M, Burrell TA, et al. Validating claims-based algorithms determining pregnancy outcomes and gestational age using a linked claims-electronic medical record database. Drug Saf. 2021;44(11):1151–64.
doi: 10.1007/s40264-021-01113-8 pubmed: 34591264 pmcid: 8481319
Minassian C, Williams R, Meeraus WH, Smeeth L, Campbell OMR, Thomas SL. Methods to generate and validate a Pregnancy Register in the UK Clinical Practice Research Datalink primary care database. Pharmacoepidemiol Drug Saf. 2019;28(7):923–33.
doi: 10.1002/pds.4811 pubmed: 31197928 pmcid: 6618019
Andrade SE, Shinde M, Moore Simas TA, Bird ST, Bohn J, Haynes K, et al. Validation of an ICD-10-based algorithm to identify stillbirth in the Sentinel system. Pharmacoepidemiol Drug Saf. 2021;30(9):1175–83.
doi: 10.1002/pds.5300 pubmed: 34089206
Martin JA, Hamilton BE, Osterman MJK, Driscoll AK. Births: final data for 2019. Natl Vital Stat Rep. 2021;70(2):1–51.
pubmed: 35157571
Winterstein AG, Thai TN, Nduaguba S, Smolinski NE, Wang X, Sahin L, et al. Risk of fetal or neonatal death or neonatal intensive care unit admission associated with gadolinium magnetic resonance imaging exposure during pregnancy. Am J Obstet Gynecol. 2022. https://doi.org/10.1016/j.ajog.2022.10.005 .
doi: 10.1016/j.ajog.2022.10.005 pubmed: 36565900
Li Y, Zhu Y, Chen C, Wang X, Choi Y, Henriksen C, et al. Internal validation of Medicaid Analytic eXtract (MAX) data capture for comprehensive managed care plan enrollees from 2007 to 2010. Pharmacoepidemiol Drug Saf. 2018;27(10):1067–76.
doi: 10.1002/pds.4365 pubmed: 29210142
Likis FE, Sathe NA, Carnahan R, McPheeters ML. A systematic review of validated methods to capture stillbirth and spontaneous abortion using administrative or claims data. Vaccine. 2013;31(Suppl 10):K74-82.
doi: 10.1016/j.vaccine.2013.03.076 pubmed: 24331077
Jones RK, Jerman J. Abortion incidence and service availability in the United States, 2014. Perspect Sex Reprod Health. 2017;49(1):17–27.
doi: 10.1363/psrh.12015 pubmed: 28094905 pmcid: 5487028
Duke CW, Correa A, Romitti PA, Martin J, Kirby RS. Challenges and priorities for surveillance of stillbirths: a report on two workshops. Public Health Rep. 2009;124(5):652–9.
doi: 10.1177/003335490912400507 pubmed: 19753943 pmcid: 2728657
Hoyert DL, Gregory ECW. Cause-of-death data from the fetal death file, 2015–2017. Natl Vital Stat Rep. 2020;69(4):1–20.
pubmed: 32510319
Thai TN, Rasmussen SA, Smolinski NE, Nduaguba S, Zhu Y, Bateman BT, et al. Implication of maternal continuous enrollment on stillbirth gestational age distributions and maternal characteristics in Medicaid enrollees. Am J Epidemiol. 2022. https://doi.org/10.1093/aje/kwac206 .
doi: 10.1093/aje/kwac206
Palmsten K, Huybrechts KF, Mogun H, Kowal MK, Williams PL, Michels KB, et al. Harnessing the Medicaid Analytic eXtract (MAX) to evaluate medications in pregnancy: design considerations. PLoS ONE. 2013;8(6): e67405.
doi: 10.1371/journal.pone.0067405 pubmed: 23840692 pmcid: 3693950
Adam MP, Polifka JE, Friedman JM. Evolving knowledge of the teratogenicity of medications in human pregnancy. Am J Med Genet C Semin Med Genet. 2011;157C(3):175–82.
doi: 10.1002/ajmg.c.30313 pubmed: 21766440
Suarez EA, Bateman BT, Hernández-Díaz S, Straub L, Wisner KL, Gray KJ, et al. Association of antidepressant use during pregnancy with risk of neurodevelopmental disorders in children. JAMA Intern Med. 2022;182(11):1149–60.
doi: 10.1001/jamainternmed.2022.4268 pubmed: 36190722
Bateman BT, Hernandez-Diaz S, Straub L, Zhu Y, Gray KJ, Desai RJ, et al. Association of first trimester prescription opioid use with congenital malformations in the offspring: population based cohort study. BMJ. 2021;372: n102.
doi: 10.1136/bmj.n102 pubmed: 33568363 pmcid: 7873721
Thai TN, Sarayani A, Wang X, Albogami Y, Rasmussen SA, Winterstein AG. Risk of pregnancy loss in patients exposed to mycophenolate compared to azathioprine: a retrospective cohort study. Pharmacoepidemiol Drug Saf. 2020;29(6):716–24.
doi: 10.1002/pds.5017 pubmed: 32347619
Huybrechts KF, Bateman BT, Zhu Y, Straub L, Mogun H, Kim SC, et al. Hydroxychloroquine early in pregnancy and risk of birth defects. Am J Obstet Gynecol. 2021;224(3):290.e1-290.e22.
doi: 10.1016/j.ajog.2020.09.007 pubmed: 32961123

Auteurs

Sabina O Nduaguba (SO)

Department of Pharmaceutical Systems and Policy, College of Pharmacy, West Virginia University, Morgantown, WV, USA.
West Virginia University Cancer Institute, Morgantown, WV, USA.
Department of Pharmaceutical Outcomes and Policy, College of Pharmacy, University of Florida, 1225 Center Drive, PO Box 100496, Gainesville, FL, 32611, USA.

Nicole E Smolinski (NE)

Department of Pharmaceutical Outcomes and Policy, College of Pharmacy, University of Florida, 1225 Center Drive, PO Box 100496, Gainesville, FL, 32611, USA.

Thuy N Thai (TN)

Department of Pharmaceutical Outcomes and Policy, College of Pharmacy, University of Florida, 1225 Center Drive, PO Box 100496, Gainesville, FL, 32611, USA.
Faculty of Pharmacy, Ho Chi Minh City University of Technology (HUTECH), Ho Chi Minh City, Vietnam.

Steven T Bird (ST)

Division of Epidemiology, Office of Surveillance and Epidemiology, Center for Drug Evaluation and Research, Food and Drug Administration, Silver Spring, MD, USA.

Sonja A Rasmussen (SA)

Center for Drug Evaluation and Safety (CoDES), University of Florida, Gainesville, FL, USA.
Department of Epidemiology, College of Public Health and Health Professionals and College of Medicine, University of Florida, Gainesville, FL, USA.
Department of Pediatrics and Obstetrics and Gynecology, College of Medicine, University of Florida, Gainesville, FL, USA.

Almut G Winterstein (AG)

Department of Pharmaceutical Outcomes and Policy, College of Pharmacy, University of Florida, 1225 Center Drive, PO Box 100496, Gainesville, FL, 32611, USA. almut@cop.ufl.edu.
Center for Drug Evaluation and Safety (CoDES), University of Florida, Gainesville, FL, USA. almut@cop.ufl.edu.
Department of Epidemiology, College of Public Health and Health Professionals and College of Medicine, University of Florida, Gainesville, FL, USA. almut@cop.ufl.edu.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH